News
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
Jordan Hill allegedly claimed to have businesses with monthly payrolls ranging from $4,000 to $210,000, using fake documents ...
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
A review meeting was also held with top officials on Monday to take stock of the situation --- with the union health ministry ...
Explore more
What sets JN.1 apart is a unique mutation in the spike protein — the part of the virus that binds to human cells. This ...
Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm ...
3hon MSN
Indian health authorities are monitoring rising COVID-19 cases in Singapore and Hong Kong while asserting that the situation ...
The Food and Drug Administration will soon “unleash a massive framework” for how vaccines are tested and approved.
Govt says Covid-19 situation remains under control despite a minor uptick in cases, amid rising infections in Singapore and ...
JN.1 may not be more severe, but it spreads fast, and that’s reason enough to stay alert. Across Asia, the priority is clear: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results